
Swiss M&A Report: Consumer Markets
This edition of the Swiss M&A Report is aimed at anyone interested in the M&A environment in the consumer markets sector in Switzerland.
Patient-centredness, quality and efficiency are not conflicting ideas – in fact they are mutually dependent. Hospitals and other stakeholders in the field of healthcare are faced with new and complex tasks that require detailed advisory services.
We can help with our proven methods and years of experience – whether you manage a central or primary care hospital, a psychiatric facility or another institution in the healthcare industry. Why not join the many providers in the Swiss healthcare industry who rely on our specialist expertise?
Philip Sommer
Partner, Head of Healthcare Services Industry and Healthcare Advisory
We support hospitals in preparing to meet the challenges of the future. In doing so, we work with you to strengthen your strategic positioning so that you can focus on providing a clearly defined range of services. We outline how you can occupy an attractive niche or otherwise stand out in the market, and suggest which organisational and business models will boost your positioning. Through our tried-and-tested strategy advice, we give you the appropriate tools to develop a forward-looking hospital strategy, backed up by data and the necessary experience, and enable you to stay on track while implementing it together with your employees.
As an outpatient service provider, you need to future-proof your outpatient and intermediate services, pursue an appropriate services strategy and develop the associated operating concepts. For example, you should formulate ideal models for outpatient locations, outpatient units within your hospital and other outpatient services and optimise them according to needs.
We help improve your efficiency in the outpatient and intermediate service spectrum and ensure you make optimal use of your resources, including employees and infrastructure. At the same time, it’s important that your facility remains attractive for employees and patients. We present you with the latest market developments, trends and demand forecasts in a clear format, explain new forms of care, and use workshops to develop innovative concepts for an outpatient and intermediate care structure that is perfectly adapted to your situation. We work with you to align your outpatient service delivery so that you stand out against the competition and continue to be a frontrunner in the outpatient market.
This edition of the Swiss M&A Report is aimed at anyone interested in the M&A environment in the consumer markets sector in Switzerland.
The US government's new measures and executive order are creating a complex regulatory environment for the pharmaceutical industry.
Hyperpersonalisation is already radically changing the way industries including online retail and entertainment interact with their customers. It’s also being adopted by companies in pharma and life sciences. What do companies need to do to put hyperpersonalisation into practice?
Dealmaking took a hit in 2024 with the number and total value of M&A deals in the Pharma & Life Science and Health Service sectors dropping to pre-2020 levels. However, the markets have seen a number of large-scale transactions in Big Pharma, each with a clear strategic rationale, such as ‘divest to invest’ motives or...
Philip Sommer
Gerhard Siegrist
Partner, Wirtschaftsprüfung, Leiter Geschäftsstelle Aarau, Aarau, PwC Switzerland
+41 58 792 26 10
Paul Sailer